2011
DOI: 10.1016/j.fct.2011.04.015
|View full text |Cite
|
Sign up to set email alerts
|

A mechanism of apigenin-induced apoptosis is potentially related to anti-angiogenesis and anti-migration in human hepatocellular carcinoma cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
36
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(38 citation statements)
references
References 21 publications
2
36
0
Order By: Relevance
“…Further antiangiogenic mechanisms are downregulation of type I collagen, vimentin, matrix metalloproteinase 8, and of the cytokine IL6/STAT3 pathway [63, 64]. …”
Section: Discussionmentioning
confidence: 99%
“…Further antiangiogenic mechanisms are downregulation of type I collagen, vimentin, matrix metalloproteinase 8, and of the cytokine IL6/STAT3 pathway [63, 64]. …”
Section: Discussionmentioning
confidence: 99%
“…Apigenin has been shown either to directly induce apoptosis or to sensitize cells to other pro-apoptotic stimuli in cancer cell lines of oral,43 esophageal,44,45 colorectal,26,4648 hepatic,49,50 and pancreatic51 cancers. Recent work in pancreatic carcinoma has indicated the possibility that apigenin was capable to promote cell cycle arrest and induction of apoptosis through p53-related pathways, even where cancers harbor mutations of the p53 tumor suppressor 38…”
Section: Role Of Apigenin In Apoptosismentioning
confidence: 99%
“…Apigenin has received increasing attention due to its bioactive properties such as anti-inflammatory (Wang & Huang, 2013), anti-mutagenic (Patel, Modi, Chiosis, & Taldone, 2011) and, particularly, antiangiogenic and anticancer properties (Choudhury et al, 2013;He et al, 2015;Johnson & Mejia, 2013). This flavone has shown the capacity to inhibit the cellular proliferation of several cancer cell lines such as hepatocellular (Kim, Jeon, & Nam, 2011), pancreatic (He et al, 2015;Johnson & Mejia, 2013), colorectal (Banerjee & Mandal, 2015), multiple myeloma (Zhao et al, 2011) and leukemia (Budhraja et al, 2012), prevent the growth of new blood vessels (metastasis) (Osada, Imaoka, & Funae, 2004), change the microenvironment of the cancer cells growth and reduce the cancer cells glucose uptake (Lefort & Blay, 2013).…”
Section: Introductionmentioning
confidence: 99%